Concomitant bilastine and montelukast as additive therapy for seasonal allergic rhinoconjunctivits and mild-to-moderate asthma. The SKY study

Allergy. 2020 Mar;75(3):675-677. doi: 10.1111/all.14007. Epub 2019 Oct 24.
No abstract available

Publication types

  • Letter

MeSH terms

  • Acetates / therapeutic use
  • Anti-Asthmatic Agents* / therapeutic use
  • Asthma* / drug therapy
  • Benzimidazoles
  • Cyclopropanes
  • Humans
  • Piperidines
  • Quinolines* / therapeutic use
  • Seasons
  • Sulfides

Substances

  • Acetates
  • Anti-Asthmatic Agents
  • Benzimidazoles
  • Cyclopropanes
  • Piperidines
  • Quinolines
  • Sulfides
  • montelukast
  • bilastine